Genmab — Marts 2020
-
Genmab A/S (GMAB) Stock Price, News, Quote & History - Yahoo Finance
Find the latest Genmab A/S (GMAB) stock quote, history, news and other vital information to help you with your stock trading and investing.
Yahoo Finance (finance.yahoo.com)
-
Vincent Rajkumar
@VincentRK
·
7 t
Today @US_FDA
@FDAOncology
approved isatuximab (Sarclisa) for relapsed refractory myeloma.Im happy that @SanofiUS
has priced it significantly lower than daratumumab. I hope there is a price war, & prices drop more. Based on cost, I’ll prefer Isa-PomDex to Dara-PomDex. @mtmdphd -
Vincent Rajkumar
@VincentRK
·
7 t
I was an author on the isatuximab pivotal trial. Im working with both @sanofi
and @JanssenUS
on other trials.Look forward to thoughts on how we support the appropriate choice of drug taking cost into account from @Rfonsi1
@akeithstewart
@peterbachmd
& others who are interested -
#ACTRIMS2020 – Results of Ofatumumab Self-injection Pen Equivalent to Infusion, APLIOS Trial Shows https://multiplesclerosisnewstoday.com/news-posts/2020/02/28/actrims2020-poster-session-lb300-onset-of-b-cell-depletion-with-subcutaneous-administration-of-ofatumumab-in-relapsing-multiple-sclerosis-results-from-the-aplios-bioequivalence-study
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind